{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T15:12:27Z","timestamp":1717513947526},"reference-count":29,"publisher":"Wiley","issue":"21","license":[{"start":{"date-parts":[[2006,10,4]],"date-time":"2006-10-04T00:00:00Z","timestamp":1159920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J of Med Genetics Pt A"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is wide variability in conditions included in state newborn screening (NBS) panels. The American College of Medical Genetics (ACMG) was commissioned by Health Resources and Services Administration to develop a uniform NBS panel. Based on survey data, the ACMG committee proposed a panel that included cystic fibrosis (CF) and glucose\u20106\u2010phosphate dehydrogenase deficiency (G6PD), although G6PD was excluded from their final recommendations. We examine the attitudes of pediatricians and genetic counselors concerning screening for these two conditions. Data were collected as part of two different studies. Koopmans and Ross surveyed a random sample of 600 pediatricians from four states based on their NBS panels. Hiraki et al. surveyed genetic counselors who were members of the National Society of Genetic Counselors (NSGC) listserv. For this analysis, we compare the health care professionals' (HCPs') attitudes toward a universal NBS program for CF and G6PD, and how their support is influenced by state policy and personal interest in testing their own children. Two hundred twenty\u2010three pediatricians and 267 genetic counselors provided partial or complete responses. Pediatricians are more likely to support NBS for both CF (84%) and G6PD (58%) than genetic counselors (56%,<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001 and 39%,<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, respectively). Both pediatricians and genetic counselors' attitudes toward screening correlate with interest in screening their own children (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Interest in CF screening also correlates with state policy (pediatricians,<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001; genetic counselors,<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.025). The correlation of professional recommendations with state policies and personal preferences reinforces the need for systematic evidence\u2010based reviews rather than reliance on stakeholder opinions for developing national guidelines. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajmg.a.31463","type":"journal-article","created":{"date-parts":[[2006,10,4]],"date-time":"2006-10-04T21:28:34Z","timestamp":1159997314000},"page":"2305-2311","source":"Crossref","is-referenced-by-count":11,"title":["Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: Implications for policy"],"prefix":"10.1002","volume":"140A","author":[{"given":"Joy","family":"Koopmans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lainie Friedman","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,10,4]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0453"},{"key":"e_1_2_7_3_1","unstructured":"American College of Medical Genetics (ACMG)\/Health Resources and Services Administration (HRSA).2005.Newborn screening: Toward a uniform screening panel and system. Available at:ftp:\/\/ftp.hrsa.gov\/mchb\/genetics\/screeningdraftforcomment.pdf."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(97)00126-1"},{"key":"e_1_2_7_5_1","unstructured":"BotkinJR.2003.Newborn screening for cystic fibrosis. Meeting sponsored by the Centers for Disease Control and Prevention and the Cystic Fibrosis Foundation (CFF). Written transcript of meeting summary (copy text available from corresponding author)."},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2571"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2547"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1084-2756(98)80146-2"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19970303)69:1<23::AID-AJMG5>3.0.CO;2-U"},{"key":"e_1_2_7_10_1","unstructured":"Centers for Disease Control and Prevention.1997.Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development. Proceedings of a 1997 Workshop. 46(RR16):1\u201322."},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.1.6"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02600842"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.2.11.1119"},{"key":"e_1_2_7_14_1","unstructured":"GrosseSD BoyleCA BotkinJR ComeauAM KharraziM RosenfeldM WilfondBS.2004.Newborn screening for cystic fibrosis: Evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR 53(RR13): 1\u201036."},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2294"},{"key":"e_1_2_7_16_1","first-page":"50","article-title":"Attitudes toward genetic testing: gender, role, and discipline","volume":"24","author":"Harman LB","year":"2003","journal-title":"Top Health Inf Manage"},{"key":"e_1_2_7_17_1","doi-asserted-by":"crossref","unstructured":"HarrisRP HelfandM WoolfSH LohrKN MulrowCD TeutschSM AtkinsD for the Methods Word Group third U.S. Preventive Services Task Force.2001.Current methods of the U.S. Preventive Services Task Force: a review of the process. Am J Prev Med 20(3S):21\u201035.","DOI":"10.1016\/S0749-3797(01)00261-6"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.31485"},{"key":"e_1_2_7_19_1","volume-title":"Proceed with caution: Predicting genetic risks in the recombinant DNA era","author":"Holtzman NA","year":"1989"},{"key":"e_1_2_7_20_1","volume-title":"Unequal treatment: Confronting racial and ethnic disparities in health care","author":"Institute of Medicine","year":"2003"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1990"},{"key":"e_1_2_7_22_1","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta3080","article-title":"Screening for cystic fibrosis","volume":"3","author":"Murray J","year":"1999","journal-title":"Health Technol Assess"},{"key":"e_1_2_7_23_1","unstructured":"National Newborn Screening Status Report.2005. Last updated 12\/22\/2005. On the web at:http:\/\/genes\u2010r\u2010us.uthscsa.edu\/nbsdisorders.pdf."},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp058060"},{"key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF03404414","article-title":"The influence of prevalence and policy on the likelihood that a physician will offer HIV screening in pregnancy","volume":"93","author":"O'Connor KS","year":"2002","journal-title":"Can J Public Health"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.24.2985"},{"key":"e_1_2_7_27_1","volume-title":"Neonatal and perinatal screening","author":"Stephen T","year":"1997"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1997.02170430027005"},{"key":"e_1_2_7_29_1","first-page":"69","article-title":"Joint Newborn Screening Committee, Human Genetics Society of Australasia. Royal Australasian College of Physicians. Newborn screening in Australia and New Zealand","volume":"34","author":"Webster D","year":"2003","journal-title":"Southeast Asian J Trop Med Publ Health"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195128307.003.0004"}],"container-title":["American Journal of Medical Genetics Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajmg.a.31463","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajmg.a.31463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T22:08:25Z","timestamp":1707257305000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajmg.a.31463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,4]]},"references-count":29,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.1002\/ajmg.a.31463"],"URL":"https:\/\/doi.org\/10.1002\/ajmg.a.31463","archive":["Portico"],"relation":{},"ISSN":["1552-4825","1552-4833"],"issn-type":[{"value":"1552-4825","type":"print"},{"value":"1552-4833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,4]]}}}